secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0000310764-22-000089
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 organic sales +6.1% to $4.5B; lowers FY adjusted EPS guidance to $9.30-$9.50
--------------------------------------------------------------------------------

- Reported net sales of $4.5B (+4.6% YoY); organic net sales +6.1%.
- Reported EPS $1.72 (+11%); adjusted EPS of $2.25 flat YoY.
- MedSurg & Neurotechnology organic sales +7.9%; Orthopaedics & Spine organic +3.9%.
- Adjusted operating margin contracted 220 bps to 23.7%; FY22 organic sales guidance raised to 8-9%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/0000310764-22-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/syk-20220726.htm
  HTML page:      https://secwatch.observer/filing/0000310764-22-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer